124 related articles for article (PubMed ID: 16337357)
1. Analysis of the antimalarial drug halofantrine and its major metabolite N-desbutylhalofantrine in human plasma by high performance liquid chromatography.
Kolade YT; Babalola CP; Scriba GK
J Pharm Biomed Anal; 2006 Apr; 41(1):315-9. PubMed ID: 16337357
[TBL] [Abstract][Full Text] [Related]
2. Ion-pair reversed-phase high-performance liquid chromatographic analysis of halofantrine and desbutylhalofantrine in human plasma.
Onyeji CO; Aideloje SO
Ther Drug Monit; 1997 Dec; 19(6):682-7. PubMed ID: 9421111
[TBL] [Abstract][Full Text] [Related]
3. Direct determination of the enantiomers of the antimalarial drug halofantrine and its active metabolite N-desbutylhalofantrine in human plasma.
Terefe H; Blaschke G
J Chromatogr B Biomed Appl; 1994 Jul; 657(1):238-42. PubMed ID: 7952076
[TBL] [Abstract][Full Text] [Related]
4. Determination of halofantrine and its main metabolite desbutylhalofantrine in rat plasma by high-performance liquid chromatography with on-line UV irradiation and peroxyoxalate chemiluminescence detection.
Amponsaa-Karikari A; Kishikawa N; Ohyama K; Nakashima K; Kuroda N
Biomed Chromatogr; 2009 Jan; 23(1):101-6. PubMed ID: 18823073
[TBL] [Abstract][Full Text] [Related]
5. Effect of kolanut on the pharmacokinetics of the antimalarial drug halofantrine.
Kolade YT; Babalola CP; Olaniyi AA; Scriba GK
Eur J Clin Pharmacol; 2008 Jan; 64(1):77-81. PubMed ID: 17952423
[TBL] [Abstract][Full Text] [Related]
6. Measurement of halofantrine and its major metabolite desbutylhalofantrine in plasma and blood by high-performance liquid chromatography: a new methodology.
Mberu EK; Muhia DK; Watkins WM
J Chromatogr; 1992 Oct; 581(1):156-60. PubMed ID: 1430001
[TBL] [Abstract][Full Text] [Related]
7. Comparative determination of halofantrine tablets by titrimetry, spectrophotometry and liquid chromatography.
Kolade YT; Adegbolagun OM; Idowu OS; Bahalola CP; Olaniyi AA
Afr J Med Med Sci; 2006 Mar; 35(1):79-84. PubMed ID: 17209332
[TBL] [Abstract][Full Text] [Related]
8. Direct determination of the enantiomers of halofantrine and its pharmacologically active metabolite N-desbutylhalofantrine by high-performance liquid chromatography.
Terefe H; Blaschke G
J Chromatogr; 1993 Jun; 615(2):347-51. PubMed ID: 8335715
[TBL] [Abstract][Full Text] [Related]
9. A simplified liquid chromatography assay for the quantitation of halofantrine and desbutylhalofantrine in plasma and identification of a degradation product of desbutylhalofantrine formed under alkaline conditions.
Humberstone AJ; Currie GJ; Porter CJ; Scanlon MJ; Charman WN
J Pharm Biomed Anal; 1995 Mar; 13(3):265-72. PubMed ID: 7619886
[TBL] [Abstract][Full Text] [Related]
10. A high-performance liquid chromatographic assay for the determination of desbutylhalofantrine enantiomers in rat plasma.
Brocks DR
J Pharm Pharm Sci; 2001; 4(1):24-31. PubMed ID: 11302787
[TBL] [Abstract][Full Text] [Related]
11. New solid-phase extraction for an improved high-performance liquid chromatographic procedure for the quantitation of halofantrine and monodesbutylhalofantrine in blood or plasma.
Gaillard Y; Prévosto JM; Cheminel V; Soares O; Chaulet JF
J Chromatogr B Biomed Appl; 1995 Jun; 668(2):315-21. PubMed ID: 7581867
[TBL] [Abstract][Full Text] [Related]
12. An improved high-performance liquid chromatographic method for the simultaneous measurement of halofantrine and desbutylhalofantrine in human serum.
Keeratithakul D; Teja-Isavadharm P; Shanks GD; Webster HK; Edstein MD
Ther Drug Monit; 1991 Jan; 13(1):64-8. PubMed ID: 2057994
[TBL] [Abstract][Full Text] [Related]
13. High-performance liquid chromatography method for determining alendronate sodium in human plasma by detecting fluorescence: application to a pharmacokinetic study in humans.
Yun MH; Kwon KI
J Pharm Biomed Anal; 2006 Jan; 40(1):168-72. PubMed ID: 16095861
[TBL] [Abstract][Full Text] [Related]
14. Measurement of lumefantrine and its metabolite in plasma by high performance liquid chromatography with ultraviolet detection.
Khalil IF; Abildrup U; Alifrangis LH; Maiga D; Alifrangis M; Hoegberg L; Vestergaard LS; Persson OP; Nyagonde N; Lemnge MM; Theander TG; Bygbjerg IC
J Pharm Biomed Anal; 2011 Jan; 54(1):168-72. PubMed ID: 20832961
[TBL] [Abstract][Full Text] [Related]
15. Effect of fluconazole on the pharmacokinetics of halofantrine in healthy volunteers.
Babalola CP; Kolade YT; Olaniyi AA; Adedapo A; Scriba GK
J Clin Pharm Ther; 2009 Dec; 34(6):677-82. PubMed ID: 20175801
[TBL] [Abstract][Full Text] [Related]
16. A liquid chromatographic assay for the stereospecific quantitative analysis of halofantrine in human plasma.
Brocks DR; Dennis MJ; Schaefer WH
J Pharm Biomed Anal; 1995 Jun; 13(7):911-8. PubMed ID: 8562616
[TBL] [Abstract][Full Text] [Related]
17. Assay of artemether, methylparaben and propylparaben in a formulated paediatric antimalarial dry suspension.
Atemnkeng MA; Marchand E; Plaizier-Vercammen J
J Pharm Biomed Anal; 2007 Jan; 43(2):727-32. PubMed ID: 17074460
[TBL] [Abstract][Full Text] [Related]
18. HPLC determination of polydatin in rat biological matrices: application to pharmacokinetic studies.
Gao S; Fan G; Hong Z; Yin X; Yang S; Wu Y
J Pharm Biomed Anal; 2006 Apr; 41(1):240-5. PubMed ID: 16459048
[TBL] [Abstract][Full Text] [Related]
19. Determination of oleanolic acid in human plasma and study of its pharmacokinetics in Chinese healthy male volunteers by HPLC tandem mass spectrometry.
Song M; Hang TJ; Wang Y; Jiang L; Wu XL; Zhang Z; Shen J; Zhang Y
J Pharm Biomed Anal; 2006 Jan; 40(1):190-6. PubMed ID: 16126358
[TBL] [Abstract][Full Text] [Related]
20. Quantitative determination of insulin entrapment efficiency in triblock copolymeric nanoparticles by high-performance liquid chromatography.
Xu X; Fu Y; Hu H; Duan Y; Zhang Z
J Pharm Biomed Anal; 2006 Apr; 41(1):266-73. PubMed ID: 16303273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
